CompletedPhase 1

Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations

Australia18 participantsStarted 1999-09

Plain-language summary

Transcranial magnetic stimulation (TMS) involves the use of magnetic fields to non-invasively stimulate the brain. Studies overseas have suggested this may be an effective and safe treatment for auditory hallucinations in patients with schizophrenia. This is a sham-controlled, double-blind trial of TMS stimulation for the treatment of auditory hallucinations in patients with schizophrenia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Over 18, with DSM-IV diagnosis of Schizophrenia and auditory hallucinations of clear external origins, refractory to pharmacotherapy and occurring at least 5 times per day. Exclusion Criteria: * Subjects with contraindications to TMS (e.g. epilepsy, pacemaker) or those with an unacceptably high risk (e.g. suicide risk) will be excluded from the study.

What they're measuring

Daily Voices Ratings (Mental Health Research Institute, Victoria)

Timeframe: Daily

Trial details

NCT IDNCT00763841

SponsorThe University of New South Wales

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-09

View on ClinicalTrials.gov More Auditory Hallucinations trials